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Crystal Structure of an Hsp90±Geldanamycin
Complex: Targeting of a Protein Chaperone
by an Antitumor Agent
Charles E. Stebbins,*‖ Alicia A. Russo,²‖ The antitumor effects of geldanamycin likely result
from its ability to deplete cells of two broad classes ofChristine Schneider,³ Neal Rosen,§
growth-regulatory signaling proteins: (1) proto-onco-F. Ulrich Hartl,³ and Nikola P. Pavletich²
genic protein kinases, including the erbB2 (Miller et al.,*Department of Biochemistry and Structural
1994; Chavany et al., 1996) and EGF (Murakami et al.,Biology
1994) receptor tyrosine kinases, the v-src family of non-Cornell University Graduate School of Medical
receptor tyrosine kinases (June et al., 1990; Xu and Lind-Sciences
quist, 1993; Hartson and Matts, 1994; Whitesell et al.,New York, New York 10021
1994), and the Raf-1 (Schulte et al., 1995; Schneider et²Cellular Biochemistry and Biophysics Program
al., 1996) and CDK4 Ser/Thr kinases (Stepanova et al.,Memorial Sloan-Kettering Cancer Center
1996), whose overexpression, or otherwise deregula-New York, New York 10021
tion, has been observed in diverse human cancers³Cellular Biochemistry and Biophysics Program
(Bouchard et al., 1989; Hunter and Pines, 1994; Tronickand Howard Hughes Medical Institute
and Aaronson, 1995); and (2) thenuclear hormone recep-Memorial Sloan-Kettering Cancer Center
tor family, including the estrogen and androgen hor-New York, New York 10021
mone receptors (Smith et al., 1995; Nair et al., 1996;§Cell Biology and Genetics Program
Whitesell and Cook, 1996), which can drive the growthand Department of Medicine
of hormone-dependent cancers of the breast (OsborneMemorial Sloan-Kettering Cancer Center
et al., 1980) and prostate (Isaacs and Coffey, 1979),New York, New York 10021
respectively.
Initially thought to be a nonspecific kinase inhibitor,
geldanamycin's target has only recently been identifiedSummary
as the heat shock protein Hsp90 (Whitesell et al., 1994)
and its endoplasmic reticulum homolog GP96 (ChavanyThe Hsp90 chaperone is required for the activation
et al., 1996). In eukaryotes, Hsp90 has dual chaperoneof several families of eukaryotic protein kinases and
functions participating both in the conformational matu-nuclear hormone receptors, many of which are proto-
ration of the nuclear hormone receptors and the afore-oncogenic and play a prominent role in cancer. The
mentioned protein kinases, and in the cellular stressgeldanamycin antibiotic has antiproliferative and anti-
response (Bohen and Yamamoto, 1994; Jakob andtumor effects, as it binds to Hsp90, inhibits the Hsp90-
Buchner, 1994; Pratt and Welsh, 1994). These two pro-mediated conformational maturation/refolding reaction,
cesses are likely to have in common the ability of Hsp90,and results in the degradation of Hsp90 substrates.
in cooperation with Hsp70 and other factors, to preventThe structure of the geldanamycin-binding domain of
protein aggregation and mediate the ATP-dependentHsp90 (residues 9±232) reveals a pronounced pocket,
refolding of heat-denatured proteins in vitro and in vivo15 AÊ deep, that is highly conserved across species.
(Freeman and Morimoto, 1996; Schneider et al., 1996).Geldanamycin binds inside this pocket, adopting a
The best-studied Hsp90-mediated conformationalcompact structure similar to that of a polypeptide
maturation is that of the nuclear hormone receptors,chain in a turn conformation. This, and the pocket's
which require the Hsp90 system in order to acquire orsimilarity to substrate-binding sites, suggest that the
maintain a state competent to bind hormone (Bresnickpocket binds a portion of the polypeptide substrate
et al., 1989; Picard et al., 1990; Nathan and Lindquist,and participates in the conformational maturation/
1995). In this ATP-dependent reaction, an initial hor-refolding reaction.
mone receptor complex that contains Hsp90, Hsp70,
and at least two cochaperones, p60 and Hip (p48), is in
Introduction equilibrium with a complex in which the receptor is in
a metastable, nearly mature state competent to bind
Geldanamycin, and its closely related analogs herbi- hormone (Smith et al., 1995; Dittmar et al., 1996). This
mycin and macbecin, are naturally occurring antitumor nearly mature complex lacks Hsp70, p60, and Hip, but
antibiotics (DeBoer et al., 1970; Omura et al., 1979; Ono contains two new proteins, p23 and one of the three
et al., 1982). In the National Cancer Institute's (NCI) in large immunophilins, FKBP52, FKBP54, or CyP40 (Smith
vitro screen for antitumor agents, geldanamycin has et al., 1995; Dittmar et al., 1996). Upon hormone binding,
shown potent activity, achieving 50% growth inhibition the receptor is released as an active transcription factor
(GI50) at concentrations as low as 13 nM against the (Smith et al., 1995; Dittmar et al., 1996). Treatment with
most responsive cell lines, with a mean GI50 of 180 nM geldanamycin appears to block the conversion to the
against all 60 of the tumor cell lines (Supko et al., 1995). nearly mature complex, preventing hormone binding
Geldanamycin is active in mouse tumor models as well and activation, and results in the degradation of the
(Sasaki et al., 1979; Ono et al., 1982), and it has been hormone receptor (Whitesell and Cook, 1996).
selected for preclinical development as an antitumor The requirement for Hsp90 in the activation of the
agent by the NCI (Supko et al., 1995). aforementioned protein kinases has been demonstrated
both genetically (Xu and Lindquist, 1993; Aligue et al.,
1994; Nathan and Lindquist, 1995) and biochemically‖ These authors contributed equally to this work.
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Figure 1. Geldanamycin Binds the N-Termi-
nal Structural Domain of Hsp90
(A) The three structural domains of Hsp90,
identified by proteolytic digestion, are indi-
cated, together with their percent identity in
the E. coli homolog. The oligomerization ac-
tivity at the C-terminal portion has been de-
scribed (Wearsch and Nicchitta, 1996). The
digestion of residues 1±9 is consistent with
this region being absent from most Hsp90
sequences except mammalian ones. To iden-
tify the geldanamycin-binding domain, the
purified structuraldomains, at 1 mM, were incu-
bated with 2.0 mM geldanamycin (GIBCO-BRL)
each; the free drug was then separated on a
gel filtration column, monitoring absorptionat
280 nm, and the protein peaks (the C-terminal
domain absorbed weakly at 280 nm for lack
of tryptophans) were analyzed for the pres-
ence of geldanamycin by reverse-phase
HPLC, with monitoring at 310 nm. The gel
filtration protein peak of the N-terminal do-
main was the only one that contained gelda-
namycin; the molar ratio was determined to
be approximately 1:1 based on UV absorp-
tion. The composition of the two secondary
geldanamycin peaks observed in the re-
versed phase chromatography is not clear,
but they could also be produced by the addi-
tion of dithiothreitol in the absence of protein.
Geldanamycin is abbreviated as GDM.
(B) Stereo view of the geldanamycin 2Fo-Fc
electron density before any geldanamycin
atoms were built into the Hsp90 model. The
map was calculated at 2.0 AÊ and contoured
at 1.0 sigma; also shown is the refined gel-
danamycin model in a ball-and-stick repre-
sentation.
(Hartson and Matts, 1994; Chavany et al., 1996; Stepa- as a result, luciferase is retained in the Hsp90 complex in
an unfolded, degradation-sensitive state (Schneider etnova et al., 1996). This reaction is not as well understood,
but it appears to involve a subset of the molecules found al., 1996). This shifts the balance from refolding to the
proteolytic degradation of the protein (Schneider et al.,in the complexes with hormone receptors, as well as a
protein kinase±specific cofactor, p50Cdc37 (Whitelaw et 1996). Such a mechanism might also explain how, under
nonstress conditions, geldanamycin and its homologsal., 1991; Stancato et al., 1993; Cutforth and Rubin, 1994;
Stepanova et al., 1996). For some of these kinases, such cause the degradation of the signaling molecules.
To obtain insights into the function of Hsp90 in theseas Raf-1, Hsp90 association is a prerequisite for their
trafficking to theplasma membrane (Schulte etal., 1995); conformational maturation/refolding processes and its
inhibition by geldanamycin, we identified the geldana-for others, the mechanism of Hsp90-mediated activation
is not yet understood. Again, geldanamycin interferes mycin-binding domain of Hsp90 (henceforth Hsp90-
GBD), and we determined the crystal structures of thiswith Hsp90 function and induces the rapid degradation
of these kinases by the proteosome system (Murakami domain and of its complex with geldanamycin.
et al., 1994; Schulte et al., 1995; Schneider et al., 1996;
Stepanova et al., 1996). Results and Discussion
In addition to its role in the conformational maturation
of signal transduction molecules, the eukaryotic Hsp90 Isolation of the Geldanamycin-Binding
Domain of Hsp90system participates in the refolding of certain thermally
denatured polypeptides during the recovery of cells To facilitate the structural study of the geldanamycin-
Hsp90 interaction, we first used proteolytic digestionfrom heat stress (Borkovich et al., 1989). Using firefly
luciferase as a model substrate, it was demonstrated and determined that the bovine Hsp90 contains three
structural domains (Figure 1A): an N-terminal domain ofthat Hsp90 cooperates in this process with Hsp70,
Hsp40 (a DnaJ homolog), p60, Hip, and p23 (Schu- approximately 25 kDa, a middle domain of approximately
35 kDa, and a C-terminal domain of approximately 10macher et al., 1994; Schneider et al., 1996). Thus, the
Hsp90 complexes formed with the thermally denatured kDa. We then assayed the three correspondingrecombi-
nant domains of human Hsp90 for geldanamycin bindingpolypeptide resemble those of hormone receptors and
protein kinases. Geldanamycin inhibits theHsp90-medi- using gel filtration chromatography to remove excess
drug and reverse-phase HPLC to detect the bound drug,ated refolding of luciferase, both in vitro and in vivo, and,
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Table 1. Summary of Crystallographic Analysis
Diffraction Data and MIR Analysis
Crystal Unique Measured Coverage Phasing
Crystal Description Resolution (A8 ) Reflections Reflections (%) Rsym (%) Riso (%) Power Rc
Native1 I222 (108C) 2.30 13532 43812 98.0 4.4 Ð Ð Ð
Native2 I222 (21608) 1.65 34516 361958 98.2 3.8 Ð Ð Ð
Native3 P21-Mg (21608C) 2.20 11381 51794 97.7 3.5 Ð Ð Ð
GDM Complex P21 (21608C) 1.90 16906 86335 92.2 2.5 Ð Ð Ð
K2AuCl4 I222 (108C) 2.50 10254 49642 94.6 5.7 17 2.43 0.54
K2PtCl4 I222 (108C) 3.20 4713 20129 91.6 5.8 28 1.07 0.83
K2PtBr6 I222 (108C) 3.20 4831 25025 93.1 4.7 22 0.75 0.90
Sm(OAc)3 I222 (108C) 3.20 4442 16281 86.0 7.1 30 0.65 0.92
Refinement and Analysis of Atomic Models
Reflections Atoms Modeled rms Deviations (Bonds [A8 ],
Crystal Resolution (A8 ) (|F| . 2s) (Protein, Water) Rcryst/Rfree (%, %) Angles [8], B Factor [A8 2])
Native1 7.0±2.30 12445 1626, 96 16.9, 25.2 0.012, 1.7, 3.2
Native2 6.0±1.65 32524 1626, 335 19.4, 24.4 0.007, 1.6, 3.3
Native3 7.0±2.20 10845 1679, 246 18.9, Ð 0.010, 1.7, 3.2
GDM Complex 6.0±1.90 16080 1679, 288 18.9, Ð 0.009, 1.8, 3.2
Coverage is the percentage measured of the total reflections theoretically observable. Rsym 5 ShSi |Ih,i 2 Ih| / ShSi Ih,i, where Ih is the mean
intensity of the i observations of the unique reflection h. Riso 5 S | FPH 2 FP| / S|FP|, where FP and FPH are the native and derivative structure
factor amplitudes, respectively. Phasing power 5 [FH(calc)2 / (FPH(obs) 2 FPH(calc))2]1/2, where FPH(obs) and FPH(calc) are the observed and calculated
derivative structure factors, respectively. Rc 5 S||FPH 6 Fp| 2 FH(calc)| / S|FPH 6 Fp|, for centric reflections only, where FH(calc) is the calculated
heavy atom structure factor. Figure of merit 5 ,S P(a) exp(ia) / S P(a)., where P(a) is the probability distribution for the phase a. Atoms
modeled discounts hydrogen atoms. R 5 S|Fp 2 Fcalc| / SFp, where Fcalc is the calculated protein structure factor from the atomic model; Rfree
is the R factor calculated using 10% of the reflection data chosen randomly and omitted from the refinement process, whereas Rcryst is
calculated with the remaining data used in the refinement. rms. bond lengths and angles are the deviations from ideal values; the rms deviation
in B factors is calculated between covalently bonded atoms.
and determined that the N-terminal domain, which has hydrophobic core of the structure and results in a pro-
the highest sequence conservation among the three nounced pocket, about 15 AÊ deep (Figures 2B±2D). The
domains, binds geldanamycin at an approximately one pocket has the b sheet as its base and three helices
molar ratio (Figure 1A). and a loop as its walls, and contains residues highly
In crystallization experiments, the geldanamycin- conserved across species (Figure 3). The helical face of
binding domain of human Hsp90 (Hsp90-GBD, residues the sandwich also has a surface groove that leads into
9±236) produced two distinct crystal forms in which the the pocket.
structure differs by a local conformational change. The In the complex, the 560 Da geldanamycin adopts a
geldanamycin±Hsp90-GBD complex crystallized in only compact conformation and binds inside the pocket, fill-
one of the two forms. The two apo-Hsp90-GBD struc- ing all but its deepest portion (Figures 2A±2E). The
tures have been determined at 1.65 and 2.2 AÊ resolution, benzoquinone group of geldanamycin binds near the
respectively, and the structure of the geldanamycin entrance of the pocket, whereas the ansamycin ring,
complex at 1.9 AÊ resolution (Table 1, Figure 1B). having dimensions similar to those of a five amino acid
polypeptide in a turn conformation, inserts into the
pocket. There is extensive, though not complete, sur-Overall Structure of the
face complementarity between geldanamycin and theGeldanamycin±Hsp90-GBD Complex
pocket, and this allows for a high density of van derThe Hsp90-GBD has nine helices and an antiparallel b
Waals contacts. Although hydrogen bond contacts aresheet of eight strands that together fold into an a1b
fewer, there being only five of them, one pair from thesandwich (Figures 2A±2D). One face of the b sheet is
geldanamycin carbamate group (Figure 2E) can be rea-hydrophobic and packs against a layer of five helices;
sonably described as one of themost important intermo-four of these helices (H1, H2, H4, and H9) pack flatly
lecular interactions in the complex.against the b sheet, with their axes parallel to the b
The entrance and width of the pocket are likely regu-strands, while H7 packs against the b sheet at a steeper,
lated by a conformational change, as evidenced byalmost perpendicular angle. The structure has a second
structural and positional changes in three helices andlayer of helices that pack on the first layer (H5 and H6),
a loop in the two different apo-Hsp90-GBD crystal formsand two smaller helices (H3 and H8) at the periphery of
(Table 1). One of the conformations, which is essen-the sandwich (Figures 2A±2D). It is noteworthy that four
tially identical to that observed in the crystals of theof the nine helices are of the 310 type and comprise
geldanamycin±Hsp90-GBD complex, has a wide enough11.2% of the amino acids, which is significantly higher
entrance to allow geldanamycin binding. The other con-than the 3.4% average in the protein database (Barlow
formation has a narrower entrance, and it would beand Thornton, 1988). At its center, the helical face of
the sandwich has a wide opening that extends into the incompatible with geldanamycin binding.
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Figure 2. The Hsp90-GBD Is an a1b Sandwich with a Deep, Conserved Pocket where Geldanamycin Binds
(A±C) Three approximately orthogonal views of the complex. Geldanamycin atoms are colored yellow for carbon, red for oxygen, and blue
for nitrogen. In (A), all secondary structure elements are labeled, whereas in (B) and (C), only those discussed in the text are labeled for clarity.
Images were prepared with the programs MOLSCRIPT (Kraulis, 1991) and RASTER3D (Merrit and Murphy, 1994).
(D) Stereo view of the Ca trace of the complex, with every 10th residue numbered and its Ca atom highlighted as a sphere.
(E) Chemical structure of geldanamycin.
Architecture and Properties of the at its deepest portion (Asp93 and Thr184 from the b
sheet).Geldanamycin-Binding Pocket
The pocket can be described as a flat-bottomed cone: The Hsp90-GBD domain is highly conserved across
species, with 43% of its residues identical in the Esche-it is about 15 AÊ deep, 12 AÊ in diameter near its entrance,
8 AÊ midway down, and wide enough at the bottom to richia coli Hsp90 homolog. The structure reveals that
the conserved residues are not distributed homoge-hold three water molecules (Figure 4A). The bottom of
the pocket is formed by the central portionof theantipar- neously on the structure, but instead show a striking
tendency to cluster in and around the pocket, with 82%allel b sheet (strands S3, S4, and S7), and the walls by
the H2, H4, and H7 helices and the L1 loop (Figure 3). of the residues lining the interior of the pocket being
invariant from E. coli to humans (Figures 3 and 4B). ThisThe pocket is deepest by the H7 helix, which packs at
an almost perpendicular angle to the b sheet bottom, identifies thepocket as holding the key to understanding
the function of this domain. Of particular interest isand is shallowest by the L1 loop. The pocket is of mixed
hydrophobic and polar character, with roughly half of Asp93, because it is at thepocket bottom in anotherwise
mostly hydrophobic environment, and because it is con-the 17 amino acids lining its interior being hydrophobic,
a quarter polar, and a quarter charged (these residues served in all known Hsp90 homologs from 35 species.
Supporting a functional significance for this pocketare Leu48, Asn51, Asp54, Ala55, Lys58, Ile91, Asp93,
Ile96, Gly97, Met98, Asn106, Leu107, Lys112, Gly135, are mutations in the yeast homolog of Hsp90 (Hsp82)
that result in either temperature-sensitive or reducedPhe138, Val150, Thr184, and Val186; Figure 3). Although
the pocket becomes increasingly hydrophobic toward activity phenotypes (Bohen and Yamamoto, 1993; Sulli-
van and Toft, 1993; Kimura et al., 1994; Nathan andthe bottom, it retains one charged and one polar residue
Structure of an Hsp90 Domain Bound to Geldanamycin
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Figure 3. Alignment of Hsp90-GBD Sequences from Several Diverse Species
Secondary structure elements for the P21 (open) form are indicated above the sequence together with the changes observed in the I222
(closed) form. Invariant residues are highlighted in yellow, residues that make up the pocket are underlined in red, and residues that make
up the surface groove are underlined in blue. Residue solvent accessibilities are indicated with circles (open, half-closed, or closed). The
dagger symbol indicates 310 helices.
Lindquist, 1995), as well as a mutation in the Drosophila These mutations map either in the pocket (Ala55Val,
Gly95Ser, Gly183Asp) or in the immediate vicinity of theHsp90 (Hsp83) that impairs signaling by the Sevenless
receptor tyrosine kinase (Cutforth and Rubin, 1994). pocket (Thr36Asn, Ser50Leu, Ala111Thr, Thr115Ile), and
Figure 4. The Hsp90-GBD Has a Conserved Pocket That Is 15 AÊ Deep
(A) A thin slice of the Hsp90-GBD molecular surface, depicted as a white net, stressing the pocket dimensions. Red indicates surface portions
with a negative electrostatic potential, and blue those with a positive potential. The pocket is mostly polar at its entrance (Lys58 and Lys112
are shown), and it becomes predominantly hydrophobic near the bottom, except for Asp93. The approximate locations of the b sheet and of
the H7 helix are indicated; the H2 helix would be approximately above the plane of the figure, whereas the H4 helix would be below. This
image was prepared with the program GRASP (Nicholls et al., 1991).
(B) Yellow highlights the positions of residues invariant in the E. coli Hsp90 homolog; magenta highlights residues, shown in space filling
representation, where either temperature-sensitive or inactivating mutations map.
(C) Surface representation indicating the pocket and groove. Also indicated, in yellow, are several patches of exposed hydrophobic amino
acids in the vicinity of the pocket and groove. These hydrophobic residues are: Phe213 to the right of the groove in this view; Ala117, Ala121,
Ala124, Ala126, Met130, and Phe134 to the left of the groove; and Phe20, Ile104, Ala111, and Ile112 to the left of the pocket (prepared with
the program GRASP).
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change is a displacement of the L2 loop into the pocket
by more than 9 AÊ (Ca±Ca distance), whereupon the L2
loop replaces the H4 helix as one of the pocket walls.
The motion of the L2 loop is facilitated by portions of
the H4 and H5 helices undergoing helix-to-coil and coil-
to-helix transitions, respectively (Figures 3 and 5). The
H4 and H5 helices also are displaced, by up to 6 AÊ . The
functional consequence of this conformational change
is that the L2 loop acts as a gate that constricts the
pocket entrance from a width of 12 AÊ to 8 AÊ (Figure 5).
These two alternate conformations have clear elec-
tron density in their respective crystal forms and are
associated with well-packed side chain arrangements
(Figure 3). It is conceivable that this conformational
change in vitro may mimic a process that occurs in vivo
and may be involved in the regulation or functioning of
the pocket. Supporting an in vivo role for the closed
conformation is the Ala111Thr mutation on the L2 loop
that results in a temperature-sensitive phenotype in
yeast (Kimura et al., 1994). This mutation would disrupt
the closed conformation structure where Ala111 is fully
buried and participates in the hydrophobic packing of
the loop, but not the open conformation structure where
Ala111 is fully solvent exposed with no apparent struc-Figure 5. A Conformational Change Alters the Sizeand Accessibility
ture-stabilizing role.of the Pocket in the Absence of Geldanamycin
The secondary structural elements that undergo positional and con-
formational changes are shown in red for the I222 (closed) and in Structure of Geldanamycin
cyan for the P21 (open) apo-Hsp90-GBD crystal forms. Geldana- Geldanamycin consists of a closed ansa ring with amycin, in space-filling representation, is superimposed on the figure
planar benzoquinone embedded in it (Figure 2E). Theto stress the effects that the conformational change has on the
ansa ring is sterically hindered because (1) its backbonepocket size.
consists of a planar amide and three carbon-carbon
double bonds (two of them arranged in a 1,3 diene), and
(2) of its sixteen backbone atoms, nine carry nonhydro-the structure suggests that most of these mutations
gen substituents: a carbonyl, a carbamate (±OC(O)NH2),would disrupt the structural integrity of the pocket (Fig-
a hydroxyl, two methoxy, and four methyl groups (Figureures 3 and 4B).
2E).Leading to the pocket, there is a surface groove
Hsp90-bound geldanamycin is highly compact andformed by the H6 and H9 helices on the sides, and the
internally well packed (overall dimensions of about 9 3H2 helix at its bottom (Figure 4C). Its shape is not as
9 3 9 AÊ ). Its ansa ring is folded over the benzoquinone,pronounced as the pocket, being shallower (about 7±8
forming a C-clamp-like structure, with the benzoquinoneAÊ ), broader (about 15 AÊ ), and mostly polar. This groove
forming the top of the (C) and the ansa ring forming theis conserved, although not as well as the pocket, with
stem and bottom of the (C) (Figure6A). Two of the methyl73% of the residues lining its concave surface identical
groups from the ansa ring are centrally positioned toin the E. coli homolog (these residues are Asn40, Glu42,
maximize intramolecular van der Waals contacts: theIle43, Arg46, Glu47, Ser50, Ser129, Gln133, His210,
C25 methyl group from the tip of the ansa ring packsSer211, and Ile214; Figure 3). Since many of these resi-
with the benzoquinone, thus bridging the top and bot-dues are polar or charged, without any significant roles
tom halves of the (C), and the C28 methyl group packsin the structural integrity of this domain, their conserva-
with the diene carbon atoms, bridging the two sides oftion suggests that the groove may participate in intermo-
the ansa ring (Figure 6A).lecular interactions important for Hsp90 function.
This compact conformation differs from those ob-
served with free geldanamycin (Rinehart and Shield,Conformational Change Alters the Size
1976) or herbimycin (Furusaki et al., 1980), which crystal-and Accessibility of the Pocket
lize from organic solvents in significantly more open,An approximately 35 amino acid region of the Hsp90-
extended conformations. The differences are likely due,GBD structure, consisting of the H4-L2-H5-H6 secondary
in part, to the loss of coplanarity between the amidestructure elements (residues 100±134), has two different
group and the benzoquinone in Hsp90-bound geldana-conformations in the two different Apo-Hsp90-GBD
mycin, as well as to the differences in the crystallizationcrystal forms (Table 1, Figures 3 and 5). We have termed
solvents.these the ªopenº and ªclosedº conformations because
they result in different pocket size and accessibility,
with only the open conformation being compatible with Geldanamycin±Hsp90 Contacts
The tip of the geldanamycin ansa ring (bottom of [C]),geldanamycin binding.
At the center of the open-to-closed conformational which has the carbamate, C23 methoxy, and C25 and
Structure of an Hsp90 Domain Bound to Geldanamycin
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Figure 6. Hsp90-Bound Geldanamycin Adopts a Compact Conformation Reminiscent of the Letter (C) and Binds Hsp90 by Inserting the Tip
of Its Ansa Ring inside the Pocket
(A) Diagram of the bound geldanamycin conformation summarizing the hydrogen bond (dotted lines) and van der Waals (arrows) contacts it
makes with Hsp90 residues, colored brown. The oxygen atoms of geldanamycin are shown in red, nitrogen atoms in blue, and methyl groups
as closed circles; the remaining carbon atoms are not explicitly shown.
(B) Stereo view of the geldanamycin±Hsp90-GBD interactions. Geldanamycin is colored as in Figure 2A, and Hsp90 residues that make up
the pocket are colored magenta. Hydrogen bonds are indicated by green dotted lines, and the water molecule that bridges the geldanamycin
carbamate group with Asp93 is shown as a red sphere.
(C) Geldanamycin, in space-filling representation, adopts a structure that is, overall, complementary to the pocket, shown as a blue molecular
surface net. Although the fit is extensive, there remains a buried cavity at the interface with three trapped water molecules in it (colored
magenta), while a fourth water molecule hydrogen bonds with the carbamate group and Asp93. The reduced complementarity near the pocket
entrance is evident as gaps between the geldanamycin atoms and the Hsp90-GBD surface. Orientation is similar to that of Figure 4A.
C26 methyl group substituents, binds near the bottom mostly hydrophobic environment. The carbamate amino
group makes a hydrogen bond to one of the Asp93of the Hsp90 pocket and makes a high density of van
der Waals contacts, whereas the benzoquinone (top of side chain oxygen atoms, and its carbonyl oxygen atom
makes a water-bridged hydrogen bond with the other[C]) is positioned near the entrance of the pocket and
makes only a few contacts (Figures 6A and 6B). There Asp93 side chain oxygen atom (Figures 6A and 6B). The
Asp93 side chain, which has an identical conformationis extensive surface complementarity between the com-
pact geldanamycin structure and the pocket, as attested in the Apo-Hsp90 structures, also hydrogen bonds to
the Ser52 OH and the backbone amide of residue 95.by the fact that a remarkable 85% of the surface area
of geldanamycin is buried in the complex (609 AÊ 2 out of This hydrogen bond network is buried about 10 AÊ away
from the nearest solvent surface, and the low dielectric719 AÊ 2).
The most critical portion of the interface is likely to constant of this environment would significantly in-
crease the coulombic attraction due to the partialbe a hydrogen bond network between the geldanamycin
carbamate group and the Asp93 side chain from Hsp90, charges. The importance of this hydrogen bond network
is supported by structure activity studies demonstratingwhich are buried at the pocket bottom in an otherwise
Cell
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that the removal of the carbamate group, or the attach- (Schnur et al., 1995a). The structure supports this hy-
pothesis, as this position ishighly solvent exposed in thement of additional atoms to it, completely abolished
geldanamycin activity (Schnur et al., 1995b). complex and is a poor candidate for additional Hsp90
contacts.At the tip of the ansa ring, the carbamate group con-
tact is flanked by the C23 methoxy and C25 and C26 Overall, however, most modifications decreased or
eliminated activity (Schnur et al., 1995a, 1995b). Themethyl groups making high density van der Waals con-
tacts with the bottom and sides of the pocket (Figures maintenance of the carbamate group and of the closed,
cyclic nature of the ansa ring proved necessary for activ-6A and 6B). Although the surface complementarity at
the pocket bottom is extensive, there remains a buried ity (Schnur et al., 1995b), consistent with the extended
hydrogen bond network that the carbamate groupcavity filled with three water molecules near the C23
methoxy and the carbamate groups (Figure 6C). It is makes and with the importance of a closed cyclic ring
in limiting conformational flexibility, respectively.Modifi-conceivable that the cellular substrates of Hsp90 can
fill this cavity as well. Modifications to this portion of cations at other positions either had little effect or re-
duced the activity of geldanamycin in line with spacegeldanamycin, for example by adding to the C23 posi-
tion a group of 4±6 nonhydrogen atoms, could increase considerations revealed by the crystal structure. For
example, additions of small groupsto theamide nitrogenthe steric and hydrogen bond complementarity and may
yield derivatives with increased affinity for Hsp90. and to the C19 position of the benzoquinone, which are
juxtaposed in a partially solvent-exposed region of theHalfway between the pocket bottom and the surface,
the widening of the pocket causes a decrease in the complex, were tolerated (Schnur et al., 1995a, 1995b),
whereas bulky substituents at these positions reducedcomplementarity and contact density, although the fit
is still adequate to exclude bulk solvent (Figure 6C). In or eliminated activity (Schnur et al., 1995b).
Our crystal structure suggests modifications, such asthis region, the diene and the C27 methoxy groups make
van der Waals contacts, and the O5 hydroxyl group those at the C23 methoxy and C22 methyl groups dis-
cussed earlier, that could improve the steric and hydro-makes a hydrogen bond contact with Lys58 (Figures 6A
and 6B). As we get closer to the surface, the contact gen bond complementarity between geldanamycin and
Hsp90 and could thus provide analogs with increaseddensity decreases further. In this region, the C28 methyl
group appears to be in an overall unfavorable environ- Hsp90 affinity (a total synthesis of geldanamycin has
recently been reported [Miller, 1995]). In addition, byment, being within van der Waals contact distance to a
backbone carbonyl oxygen atom and a partially buried identifying which modifications are compatible with
Hsp90 binding, the structure should also help with thewater molecule (Figures 6A and 6B). The loose fit in this
region, both sterically and electrostatically, points to a improvement of geldanamycin's low plasma half-life
(Supko et al., 1995) and other pharmacological proper-potential for a significant improvement of the affinity of
geldanamycin for Hsp90 (Figure 6C). ties as well.
At the pocket entrance, the carbonyl oxygen atom of
the ansa ring makes a hydrogen bond to a backbone
Implications for Understandingamide (Phe138) at the N-terminal portion of the H7 helix
Hsp90 Function(Figures 6A and 6B). The benzoquinone, which is at the
The pocket is best considered as a substrate-bindingpocket entrance with one face solvent-exposed, makes
site, for there are extensive similarities between theonly a few contacts, and these are primarily solvent-
pocket and a typical enzyme activesite, though no cova-exposed hydrogen bonds made to long lysine chains:
lent chemistry is implied by thesimilarities. We note that:one of the benzoquinone oxygen atoms hydrogen bonds
(1) the pocket has adequate space and hydrophobicwith Lys112, and the C29 methoxy group oxygen atom
content, and is adequately shielded from bulk solventmakes a long-distance (3.5 AÊ ) hydrogen bond with
to tightly bind substrates of a few hundred daltons; (2)Lys58.
there is a nonuniform electrostatic distribution resulting
from an aspartic acid at the otherwise hydrophobic bot-Geldanamycin Derivatives
tom of the pocket; (3) the shape and size of the pocketAmong the naturally occurring homologs, geldanamycin
entrance is likely to be regulated by a conformationalis the most potent. Compared to herbimycin, for exam-
change; (4) the geldanamycin-binding domain of Hsp90ple, geldanamycin is more potent by a factor of about
is the best conserved among its three structural do-four in achieving a 50% reduction (IC50) of erbB-2 kinase
mains, and within this domain, the conserved residuesactivity in human SKBr3 breast cancer cells (Miller et
cluster in and around the pocket; (5) mutations thatal., 1994). The structure suggests that this may be due
inactivate Hsp90 map in and around the pocket; and,to the hydrogen bond that the C29 methoxy oxygen
finally, (6) the geldanamycin inhibitor of Hsp90 functionatom of geldanamycin makes with Lys58, because her-
binds inside this pocket.bimycin does not have the C29 methoxy group.
Assuming that theHsp90 pocket is a substrate bindingAmong the published synthetic derivatives (Schnur et
site, it can then directly follow that its substrate is theal., 1995a, 1995b), the highest potency, reflecting an
protein, or more precisely, a segment of the protein,improvement in the IC50 of a factor of 4±5, was achieved
whose conformational maturation/refolding is mediatedby an amino group substitution at the C17 position of
by the Hsp90 chaperone system. This pocket-polypep-the benzoquinone (Schnur et al.,1995a). It was proposed
tide association is likely to occur as a late step in thethat this and several related substitutions at the C17
reaction pathway because Hsp70, which is present inposition improved cellular activity indirectly, by stabiliz-
ing the quinone form over the reduced hydroquinone all of the early Hsp90 complexes (Smith, 1993; Smith et
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al., 1995; Dittmar et al., 1996; Johnson et al., 1996), can
bind unfolded proteins (Flynn et al., 1991; Zhu et al.,
1996) and is thus the likely initial recruiter of the unfolded
polypeptide to the Hsp90 complex. That a polypeptide
portion is the substrate for the pocket is supported by
the ability of the endoplasmic reticulum homolog, GP96,
to associate with a specific viral peptide, though it is
not yet known with which domain of GP96 this peptide
is associated (Nieland et al., 1996).
Further support is provided by the general similarities
between the geldanamycin ansa ring and a peptide. A
five amino acid polypeptide in a turn conformation could
closely trace thegeldanamycin ansa ring backbone, with
its amino acid side chains broadly corresponding to the
carbamate, methyl, and methoxy groups of geldana-
mycin (Figure 7). Furthermore, and intended only as an
example, steric and hydrogen bond complementarity
considerations suggest that a tryptophan amino acid
Figure 7. The GeldanamycinAnsa Ring Adopts a Structure Reminis-could be accommodated at the polypeptide position
cent of a Pentapeptide in a Turn Conformation
corresponding to that of the geldanamycin carbamate
Geldanamycin and Asp93 of Hsp90 are in yellow, the buried watergroup (Figure 7). The tryptophan indole amino group
molecules at the geldanamycin±Hsp90-GBD interface are in ma-
could donate a hydrogen bond to Asp93, in a manner genta, and the modeledpolypeptide is in cyan. Redand blue indicate
analogous to that of the carbamate amino group, per- oxygen and nitrogen atoms, respectively. A tryptophan at the pep-
tide position corresponding to that of the carbamate group in gel-haps explaining why Asp93 is conserved, and the hy-
danamycin could donate a hydrogen bond to Asp93 of Hsp90 anddrophobic portion of the tryptophan could fill the buried
also pack in the hydrophobic cavity now occupied by the threecavity that is now occupied by water molecules in the
water molecules. Backbone amide groups and several other amino
geldanamycin complex (Figure 7). In this region, back- acids could also hydrogen bond to Asp93, but their fit in the pocket
bone amide groups, as well as other hydrogen bond would not be as good as that of a Trp.
donor amino acids,could also satisfy thehydrogen bond
potential of Asp93, although they may not have as good
of a fit as a tryptophan in the buried cavity.
is possible; however, we note that: (1) it is unlikely thatIt is conceivable that the pocket binds a family of
such an unusual pocket would have evolved to bind arelated polypeptide sequences, and this could explain
protein cofactor; (2) p23 and the pocket could havethe conservation of the pocket residues, because a large
coevolved resulting in far lesser sequence conservationfamily of peptide sequences, in contrast to a single se-
at the pocket; and (3) E. coli and lower eukaryotes doquence, could not coevolve with amino acid changes
not seem to have p23, at least not one that is as con-in the pocket. This has precedence in the Hsp70 chaper-
served as the Hsp90-GBD.one, which has a peptide-binding channel highly con-
On the other hand, the isolation of complexes of heat-served between E. coli and humans (Zhu et al., 1996),
denatured luciferase and of Raf with Hsp90 in the pres-and binds unfolded proteins by interacting with seven-
ence of geldanamycin (Schneider et al., 1996) at firstresidue segments, having exposed hydrophobic amino
appears tobe inconsistent with thepocket binding theseacids at their central positions (Flynn et al., 1991; Zhu
substrates. It is conceivable, however, that Hsp90 con-et al., 1996).
tains additional polypeptide-interacting sites that areA model in which the polypeptide substrate binds in
not blocked by geldanamycin and that act at an earlierthe pocket along the reaction pathway would be sup-
stage. These additional sites can be either within itsported by the observation that geldanamycin causes the
geldanamycin-binding domain (for example, the con-dissociation of the v-src±Hsp90 complex in transformed
served surface groove) or in the rest of the 732 residuecells (Whitesell et al.,1994). Also consistent are observa-
protein. Alternatively, the observed association of gel-tions from the in vitro conformational maturation of the
danamycin-bound Hsp90 with theprotein substrate maysteroid receptors. In this reaction, a transient complex
be indirect, since these complexes contain several otherof the receptor that includes Hsp90, Hsp70, and several
protein cofactors, such as Hsp70, which may contributeother cofactors is in equilibrium with the hormone-
to polypeptide binding (Bose et al., 1996; Duina et al.,responsive state of the receptor, which is bound to
1996; Freeman et al., 1996; Schneider et al., 1996). InHsp90, p23, and an immunophilin (Smith et al., 1995;
any case, geldanamycin blocks the refolding of the heat-Dittmar et al., 1996; Nair et al., 1996). Geldanamycin
denatured Raf and luciferase substrates, and this ulti-blocks the formation of the latter complex, consistent
mately results in their degradation (Schneider et al.,with receptor±pocket interactions being required to ei-
1996).ther arrive at or to maintain the hormone-responsive
The crystal structure of the Hsp90-GBD reveals astate of the receptor (Smith et al., 1995; Nair et al.,
pocket whose properties indicate that it is a likely bind-1996). In principle, the interruption of this reaction by
ing site for the polypeptide substrate. That geldana-geldanamycin can be interpreted in other ways, for ex-
mycin, by binding in this pocket, inhibits the Hsp90-ample, to mean that geldanamycin directly competes
with p23 (Smith et al., 1995) binding to the pocket. This catalyzed conformational reaction both in vitro and in
Cell
248
residues 11±16 were visible and modeled, whereas two solvent-vivo strongly argues that the pocket±substrate interac-
exposed loops, 121±130 and 212±214, became partially disorderedtion is a required step in this reaction. The crystal struc-
relative to the I222 crystals. Residues in all models were in theture of this pocket, as well as that of the geldanamycin±
allowed regions of the Ramachandran plot, with 89% or more in the
pocket complex, also provides a rational basis for the most favored regions. It is not clear what causes the conformational
development of geldanamycin derivatives with improved change in vitro; the L2 loop, which changes the most, is not involved
in any significant crystal-packing contacts, though the H5 and H6antitumor activity.
helices are in both crystal forms. In addition to magnesium and
geldanamycin, the growth of the P21 form can be induced by acidicExperimental Procedures
pH as well.
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